This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Atkins, M. B. Articles by King, L. Search for Related Content PubMed PubMed Citation Articles by Atkins, M. B. Articles by King, L.

Innovations and Challenges in Melanoma: Summary Statement from the First Cambridge Conference

Authors' Affiliations: ¹ Harvard Medical School, Beth Israel Deaconess Medical Center, Boston Massachusetts; ² Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts; ³ University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; ⁴ John Wayne Cancer Institute, Santa Monica, California; ⁵ University of Chicago, Chicago, Illinois; ⁶ The University of Texas M.D. Anderson Cancer Center, Houston, Texas; ⁷ Charité, Free University Berlin, Berlin, Germany; ⁸ University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; ⁹ University of Virginia Health System, Charlottesville, Virginia; ¹⁰ H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; ¹¹ Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; ¹² Brown University, Providence, Rhode Island; and ¹³ InforMEDical Communications, Inc., Carlisle, Massachusetts

Requests for reprints: Michael B. Atkins, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Kirstein 157, Boston, MA 02215. E-mail: matkins{at}bidmc.harvard.edu.

Innovations and Challenges in Melanoma, chaired by Michael Atkins and cochaired by Ulrich Keilholz, John Kirkwood, and Jeffrey Sosman, was held July 15 to 16, 2005, in Cambridge, Massachusetts. The conference brought together leading experts in the fields of cancer research, medical oncology, surgical oncology, anatomic pathology, dermatology, and immunotherapy who wished to advance the field of melanoma treatment by exchanging information and perspectives regarding recent advances and recommendations for further study. The conference proceedings published in this educational supplement to Clinical Cancer Research are intended to provide timely information and recommendations on how genetics, biology, and data information can enhance our understanding of melanoma biology and help inform the use of therapies for this disease.

This article has been cited by other articles:

				P. A. Gimotty, D. E. Elder, D. L. Fraker, J. Botbyl, K. Sellers, R. Elenitsas, M. E. Ming, L. Schuchter, F. R. Spitz, B. J. Czerniecki, et al. Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas J. Clin. Oncol., March 20, 2007; 25(9): 1129 - 1134. [Abstract] [Full Text] [PDF]